close
close

Semainede4jours

Real-time news, timeless knowledge

Parkinson’s disease will reach 3.15 million worldwide by 2033, report says |
bigrus

Parkinson’s disease will reach 3.15 million worldwide by 2033, report says |

Parkinson's disease will reach 3.15 million worldwide by 2033, report says

Parkinson’s disease, a brain disorder that causes problems with movement, mental health, sleep, pain and other health issues, is on the rise. Number of cases in 2023 Parkinson’s disease This number, which is 2.16 million, is expected to increase to 3.15 million in 2033.
The report by GlobalData, a data and analysis company, showed that the increase in the incidence of cases diagnosed with progressive brain disorders will be seen especially in seven major countries (USA, France, Germany, Italy, Spain, United Kingdom and United Kingdom). According to the news of Japan news agency IANS.
“In 2023, adults ages 60 and older accounted for more than 90 percent of diagnosed common Parkinson’s cases, while adults ages 18 to 39 accounted for less than 1 percent. This age distribution is consistent with findings showing a higher prevalence of Parkinson’s disease in older populations.” said Rahul N Ravi, Senior Epidemiologist, GlobalData.

Parkinson’s Disease gets worse over time

Quality of life can be significantly affected after the onset of Parkinson’s disease, as it limits independence and social interactions. Feelings of frustration or isolation are common due to the progressive nature of the disease. However, treatment options including medications, physical therapy, occupational therapy, and emotional support can help manage symptoms and improve daily functioning.
Parkinson’s disease affects movement. Once diagnosed, individuals experience symptoms that can significantly impact their quality of life. These symptoms are generally classified as motor and non-motor.
Motor symptoms include tremors, rigidity, slowness of movement (bradykinesia), and postural instability, leading to difficulties in walking, balance, and coordination. Over time, these symptoms can make routine tasks such as eating, dressing, or writing more difficult. Speech and facial expressions may also be affected, reducing ease of communication.
Non-motor symptoms such as fatigue, sleep disturbances, depression, anxiety, and cognitive changes such as memory loss or difficulty concentrating are equally challenging. Digestive problems, loss of smell, and chronic pain are common and further reduce comfort and well-being.
“PD is one of the most common chronic, progressive diseases. neurodegenerative disorders It affects the elderly population. Because PD predominantly affects older adults, countries with growing aging populations must develop strategies to meet the healthcare needs of individuals with PD,” said Ravi.
He added that the seven countries with the highest risk over the next 10 years are expected to be vital for Parkinson’s treatment due to their aging populations.